Main Session
Sep
29
SS 17 - Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas
200 - TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma
Presenter(s)
Alok Deshane, MD - MSKCC, New York, NY